Transforming the treatment of severe emphysema with a unique bronchoscopic approach designed to reduce trapped air associated with hyperinflation.
Location: United States
Total raised: $130M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.08.2025 | Series B | $130M | F-Prime Ca... |
Mentions in press and media 7
| Date | Title | Description |
| 09.08.2025 | Apreo Health Secures $130M to Revolutionize Emphysema Care | Apreo Health secured $130 million in Series B funding. This major investment propels its BREATHE Airway Scaffold, an innovative medical device for severe emphysema. The scaffold addresses lung hyperinflation, aiming to redefine treatment fo... |
| 08.08.2025 | Apreo Health: $130 Million Series B Raised For Developing Treatments For Severe Emphysema | Apreo Health, a clinical-stage medical device company focused on innovative treatments for severe emphysema, has announced the successful completion of an oversubscribed $130 million Series B financing round. This funding was jointly led by... |
| 08.08.2025 | Top Startup and Tech Funding News Roundup – Week Ending August 8, 2025 | It’s Friday, August 8, 2025, and we’re back with the top startup and tech funding stories that shaped the week. From AI titans locking in multi-billion-dollar rounds to stealth-mode deep tech startups breaking cover with game-changing innov... |
| 08.08.2025 | Apreo Health nets $130M to develop lung scaffold for emphysema | After emerging from stealth earlier this year, Apreo Health has raised $130 million to breathe new life into the development of lung implants for emphysema. The financing comes through a series B round co-led by Bain Capital Life Sciences a... |
| 07.08.2025 | Top Startup and Tech Funding News – August 7, 2025 | It’s Thursday, August 7, 2025, and we’re back with today’s top startup and tech funding news from across the globe. From programmable mRNA and real-time generative AI to on-orbit defense vehicles and fintech fraud resolution, today’s deals ... |
| 07.08.2025 | Apreo Health Closes $130M in Series B Financing | Apreo Health, a Menlo Park, CA-based clinical-stage medical device company developing a novel treatment for severe emphysema, raised $130M in Series B funding. The round was led by Bain Capital Life Sciences and Norwest, with participation ... |
| - | Apreo Health | “Apreo Health” |